Lingyan Ping
Emory University(US)Peking University(CN)Peking University Cancer Hospital(CN)Ministry of Education(ET)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, CAR-T cell therapy research
Most-Cited Works
- → A safe and potent anti-CD19 CAR T cell therapy(2019)439 cited
- → Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid(2022)301 cited
- → Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma(2019)163 cited
- → Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin(2015)95 cited
- → The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages(2017)85 cited
- → A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type(2013)69 cited